Cargando…

A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice

Huntington’s disease has been associated with a failure in energy metabolism and oxidative damage. Ascorbic acid is a powerful antioxidant highly concentrated in the brain where it acts as a messenger, modulating neuronal metabolism. Using an electrophysiological approach in R6/2 HD slices, we obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acuña, Aníbal I., Esparza, Magdalena, Kramm, Carlos, Beltrán, Felipe A., Parra, Alejandra V., Cepeda, Carlos, Toro, Carlos A., Vidal, René L., Hetz, Claudio, Concha, Ilona I., Brauchi, Sebastián, Levine, Michael S., Castro, Maite A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905737/ https://www.ncbi.nlm.nih.gov/pubmed/24336051 http://dx.doi.org/10.1038/ncomms3917

Ejemplares similares

Modulating the surface expression of cold receptors
por: Toro, Carlos A, et al.
Publicado: (2015)

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility
por: Chen, Jane Y., et al.
Publicado: (2013)

Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway
por: Barry, Joshua, et al.
Publicado: (2022)

Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease
por: Cummings, Damian M, et al.
Publicado: (2010)

Calcium imaging: A versatile tool to examine Huntington’s disease mechanisms and progression
por: Barry, Joshua, et al.
Publicado: (2022)

Genetic mouse models of Huntington’s disease: focus on electrophysiological mechanisms
por: Cepeda, Carlos, et al.
Publicado: (2010)

Near-Membrane Dynamics and Capture of TRPM8 Channels within Transient Confinement Domains
por: Veliz, Luis A., et al.
Publicado: (2010)

Therapeutic potential of insulin-like growth factor 2 in Huntington’s disease: controlling proteostasis to alleviate the load of misfolded protein
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2021)

Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice
por: Holley, Sandra M., et al.
Publicado: (2019)

Cortical circuit alterations precede motor impairments in Huntington’s disease mice
por: Burgold, Johanna, et al.
Publicado: (2019)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington’s Disease: Are They Fit-for-Purpose for Treatment Development?
por: Leuchter, Michael K., et al.
Publicado: (2017)

Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease
por: Gu, Xiaofeng, et al.
Publicado: (2007)

Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease
por: Chen, Jane Y., et al.
Publicado: (2013)

Prolong psychosis preceding cognitive and motor symptoms; an unusual presentation in Huntington's disease
por: Khan, Nida, et al.
Publicado: (2021)

Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington’s Disease Mice
por: Botelho, Eliã P., et al.
Publicado: (2014)

The adjustment of γ-aminobutyric acid(A) tonic subunits in Huntington's disease: from transcription to translation to synaptic levels into the neostriatum
por: Rosas-Arellano, Abraham, et al.
Publicado: (2018)

The Alteration of Emotion Regulation Precedes the Deficits in Interval Timing in the BACHD Rat Model for Huntington Disease
por: Garces, Daniel, et al.
Publicado: (2018)

Neuronal Targets of Mutant Huntingtin Genetic Reduction to Ameliorate Huntington’s Disease Pathogenesis in Mice
por: Wang, Nan, et al.
Publicado: (2014)

On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2020)

The Integration of Electrical Signals Originating in the Root of Vascular Plants
por: Canales, Javier, et al.
Publicado: (2018)

DNA damage precedes apoptosis during the regression of the interdigital tissue in vertebrate embryos
por: Montero, Juan A., et al.
Publicado: (2016)

Sleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6/1 Huntington’s Disease Mice
por: Lebreton, Fanny, et al.
Publicado: (2015)

Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders
por: Covarrubias-Pinto, Adriana, et al.
Publicado: (2015)

Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
por: Valenza, Marta, et al.
Publicado: (2015)

Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease1,2,3
por: Holley, Sandra M., et al.
Publicado: (2015)

Proteomic Analysis of Huntington’s Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets
por: Tshilenge, Kizito-Tshitoko, et al.
Publicado: (2023)

Infections preceding the development of Dercum disease
por: Beltran, Karen, et al.
Publicado: (2019)

The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington’s Disease
por: Rosas-Arellano, Abraham, et al.
Publicado: (2018)

Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington’s disease patients
por: Askeland, Georgina, et al.
Publicado: (2018)

Editorial: Antimicrobial resistant pathogens in sustainable food systems: how to prevent, detect, or control contamination?
por: Concha-Meyer, Anibal, et al.
Publicado: (2023)

Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington’s disease
por: Bragg, Robert M., et al.
Publicado: (2017)

Diffusion imaging in Huntington’s disease: comprehensive review
por: Estevez-Fraga, Carlos, et al.
Publicado: (2021)

Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington’s Disease
por: Holley, S. M., et al.
Publicado: (2022)

Huntington’s Disease Clinical Trials Corner: August 2023
por: Estevez-Fraga, Carlos, et al.
Publicado: (2023)

Disease Onset in Huntington's Disease: When Is the Conversion?
por: Oosterloo, Mayke, et al.
Publicado: (2021)

A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s disease
por: Pérez-Arancibia, Rodrigo, et al.
Publicado: (2021)

Corrigendum: Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington’s disease
por: Bragg, Robert M., et al.
Publicado: (2017)

Chorea and Stroke. Comment: “Persistent Hemichorea as a Preceding Symptom of Cerebral Infarction”
por: Fustes, Otto J. Hernandez, et al.
Publicado: (2022)

Beyond the clinical context: the process of losing oneself living with Huntington’s disease
por: Varela, Luz-Estella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7hlltgnedcshml32fmvuspor34